ArticleBritish journal of clinical pharmacology2019

Dipeptidyl peptidase-4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population-based cohort study.

Jong-Mi Seong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.